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Abstract
Rapid detection is essential for timely initiation of medical post-exposure prophylactic measures in the event of intentional release of
biological threat agents. We compared real-time PCR assay performance between the Applied Biosystems 7300/7500 and the RAZOR
instruments for speciﬁc detection of the causative agents of anthrax, brucellosis, tularemia and plague. Furthermore, an assay detecting
Bacillus thuringiensis, a Bacillus anthracis surrogate, was developed for ﬁeld-training purposes. Assay sensitivities for B. anthracis, Brucella
spp., Francisella tularensis and Yersinia pestis were 10–100 fg of target DNA per reaction, and no signiﬁcant difference in assay perfor-
mance was observed between the instrument platforms. Speciﬁcity testing of the diagnostic panels with both instrument platforms did
not reveal any cross-reactivity with other closely related bacteria. The duration of thermocycling with the RAZOR instrument was
shorter, i.e. 40 min as compared with 100 min for the Applied Biosystems 7300/7500 instruments. These assays provide rapid tools for
the speciﬁc detection of four biological threat agents. The detection assays, as well as the training assay for B. thuringiensis powder prep-
aration analysis, may be utilized under ﬁeld conditions and for ﬁeld training, respectively.
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Introduction
Bacillus anthracis, Brucella spp., Francisella tularensis and Yersinia
pestis are zoonotic bacteria that can cause severe diseases
(anthrax, brucellosis, tularemia and plague, respectively) in
humans and animals [1–4]. Because of their ease of dissemi-
nation and the potentially high mortality rate after inhala-
tional exposure, B. anthracis, F. tularensis and Y. pestis are
classiﬁed as category A bioterrorism agents according to the
CDC. Brucella spp. are especially infectious in aerosolized
form, and can survive for long periods in the environment.
Therefore, they are classiﬁed as category B bioterrorism
agents by the CDC.
Rapid and reliable detection is essential for timely initiation
of medical post-exposure prophylactic measures in the event
of intentional release of these bacteria. The possibility of ﬁeld
testing should augment this capability, as compared with more
conventional analysis performed in stationary laboratories. On
the other hand, competence in the sampling and identiﬁcation
procedures under ﬁeld conditions requires thorough training.
The powder form of B. anthracis spores is a well-known and
highly pathogenic substance, whereas Bacillus thuringiensis is
almost harmless to humans, even though it belongs to the
same Bacillus cereus group as B. anthracis and shares many bio-
logical traits with it [5]. Therefore, the use of non-infectious
B. thuringiensis in a training assay as a substitute for B. anthracis
spores is preferable with regard to safety of the trainees.
In this study, two platforms for real-time PCR detection
of B. anthracis, Brucella spp., F. tularensis and Y. pestis were
compared. Furthermore, an assay for ﬁeld-training purposes
was developed using B. thuringiensis from a commercial pow-
der formula insecticide as template.
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Materials and Methods
Strains of bacteria
The strains used for speciﬁcity and sensitivity comparisons of
the B. anthracis, F. tularensis and Y. pestis assays [6] between
the RAZOR (Idaho Technology Inc., Salt Lake City, UT,
USA) and ABI 7300/7500 (Applied Biosystems, Foster City,
CA, USA) instruments are listed in Table 1. Strains or
batches of bacterial DNA used for the development of the
Brucella spp. and B. thuringiensis assays are listed in Tables 2
and 3, respectively. For the development of the B. thuringien-
sis assay, puriﬁed DNA from an insecticidal product
(TUREX 50WP, Certis, Columbia, MD, USA), containing
50% B. thuringiensis kurstaki-aizaway strain GC-91 (lot
010774 M08 04) was used, whereas in the ﬁeld labora-
tory training assay, the sample was prepared from this
powdery substance with a simpliﬁed procedure, as described
below.
Puriﬁcation of DNA
DNA from the B. anthracis, F. tularensis, Y. pestis and B. thurin-
giensis strains was puriﬁed using the automated MagNA Pure
Compact instrument and the MagNA Pure Nucleic Acid Iso-
lation Kit I combined with the MagNA Pure Bacterial Lysis
Buffer and proteinase K treatment (Roche, Basel, Switzer-
land), according to the manufacturer’s instructions. DNA
from the clinical Brucella isolates was puriﬁed with the Qia-
Amp DNA miniKit (Qiagen, Hilden, Germany), according to
the manufacturer’s instructions. The concentration and pur-
ity of the DNA batches were determined with the Nano-
Drop ND-1000 spectrophotometer (Thermo Scientiﬁc,
Wilmington, DE, USA).
Primer and probe selection
The primer and TaqMan minor groove binder probe
sequences developed, as well as their target genes, are listed
in Table 4. All new oligonucleotide primers and probes for
this study were designed using Primer Express software
TABLE 1. Bacterial strains used and results of the speciﬁcity testing of the Bacillus anthracis, Francisella tularensis and Yersinia
pestis real-time PCR assays on the RAZOR and ABI instruments
Species Strain Sourcea
Agent (target gene)
B. anthracis (pag) B. anthracis (cap) F. tularensis (23 kDa) Y. pestis (pla)
ABI
7300/7500 RAZOR
ABI
7300/7500 RAZOR
ABI
7300/7500 RAZOR
ABI
7300/7500 RAZOR
Agrobacterium tumefaciens C58C1/RP4 6 ) ) ) ) ) ) ) )
B. anthracis ATCC 4229
(pXO1)/pXO2+)
4 ) ) + + ) ) ) )
B. anthracis Sterne 7702
(pXO1+/pXO2))
4 + + ) ) ) ) ) )
Bacillus cereus ELMI 21 4 ) ) ) ) ) ) ) )
Bacillus licheniformis ELMI 325 4 ) ) ) ) ) ) ) )
Bacillus mycoides ELMI 44 4 ) ) ) ) ) ) ) )
Bacillus thuringiensis ELMI 123 4 ) ) ) ) ) ) ) )
B. thuringiensis ssp. kurstaki-aizaway 7 ) ) ) ) ) ) ) )
Brucella melitensis 72, biotype 3 2 ) ) ) ) ) ) ) )
Burkholderia multivorans DSM 13243 8 ) ) ) ) ) ) ) )
Enterobacter cloacae tks461 6 ) ) ) ) ) ) ) )
Escherichia coli C600/pYET6 6 ) ) ) ) ) ) ) )
Francisella philomiragia DSM 7535 8 ) ) ) ) ) ) ) )
F. tularensis LVS (ATCC 29684) 5 ) ) ) ) + + ) )
Microbacterium barkeri DSM 20145 8 ) ) ) ) ) ) ) )
Moraxella catarrhalis 035E 6 ) ) ) ) ) ) ) )
Staphylococcus aureus ATCC 25923 6 ) ) ) ) ) ) ) )
Yersinia bercovieri 3016/84 6 ) ) ) ) ) ) ) )
Yersinia enterocolitica 1309/80 6 ) ) ) ) ) ) ) )
Yersinia frederiksenii 38/83 6 ) ) ) ) ) ) ) )
Yersinia intermedia 9/85 6 ) ) ) ) ) ) ) )
Yersinia kristensenii 119/84 6 ) ) ) ) ) ) ) )
Yersinia mollaretii 92/84 6 ) ) ) ) ) ) ) )
Y. pestis EV76-c 6 ) ) ) ) ) ) + +
Y. pestis KIM D1 6 ) ) ) ) ) ) + +
Yersinia pseudotuberculosis H305-36/89 6 ) ) ) ) ) ) ) )
Y. pseudotuberculosis No. 90 6 ) ) ) ) ) ) ) )
Y. ruckeri RS41 6 ) ) ) ) ) ) ) )
aThe sources are as follows: 1, Department of Applied Chemistry and Microbiology, Faculty of Agriculture and Forestry, University of Helsinki, Finland; 2, Institute of Microbi-
ology, German Armed Forces, Munich, Germany; 3, Turku University Central Hospital and Helsinki District Central Hospital Laboratory Diagnostics HUSLAB; 4, Laboratory
Strain Collection, Finnish Food Safety Authority Evira; 5, Laboratory Strain Collection, FOI, Umea˚, Sweden; 6, Laboratory Strain Collection, Department of Bacteriology and
Immunology, University of Helsinki; 7, Puriﬁed from a commercial insecticide; 8, DSMZ, German Collection of Microorganism and Cell Cultures, Braunschweig, Germany.
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(ABI, Warrington, UK) versions 2.0 and 3.0, and synthesized
by ABI. The primers and probes were selected on the basis
of minimum dimer or secondary structure formation and
minimum homology with other known prokaryotic gene
sequences.
Out of several primer pairs and probes initially designed
and tested for the genus-speciﬁc Brucella spp. assay, those
selected were based on the Brucella melitensis strain 16M
insertion sequence IS711 (GenBank accession num-
ber NC003317.1, derived from reference sequen-
ce AE008917), which is highly conserved in the genus
Brucella, with varying locations and copy numbers in each
species [7–9]. This target has been used previously in Brucella
species-speciﬁc real-time PCR assays [10,11].
The ability to produce crystal toxins, encoded by mainly
plasmid-located crystalline genes (cry genes), is mostly
responsible for the speciﬁc insecticidal activity of B. thuringi-
ensis species, and accounts for the use of these microbes as
insecticides [12–14]. The cry1Ac gene (accession num-
ber U87397) of B. thuringiensis ssp. kurstaki, a bacterium pres-
ent in the commercial insecticidal powder formula, was used
as a target in the developed training assay for Bacillus spore
detection. The gene fragment predicted to be produced by
the designed primers on the basis of the B. thuringiensis ssp.
TABLE 2. Bacterial strains used for
the speciﬁcity testing of the Bru-
cella spp. (IS711)-speciﬁc PCR
assay
Species Strain Sourcea
Results
ABI 7300/7500 RAZOR
Agrobacterium rhizogenes HAMBI 1816 T 1 ) )
Agrobacterium tumefaciens HAMBI 1811 T 1 ) )
Agrobacterium vitis HAMBI 1817 T 1 ) )
Bacillus anthracis ATCC 4229 4 ) )
B. anthracis Sterne 7702 4 ) )
Bacillus thuringiensis ssp. kurstaki-aizaway 7 ) )
Bradyrhizobium japonicum HAMBI 2314 T 1 ) )
Brucella spp. Eight clinical isolates 3 + +
Brucella abortus 7, biotype 6 2 + +
Brucella abortus 91, biotype 1 2 + +
Brucella abortus 101, biotype 3 2 + +
Brucella abortus 120, biotype 4 2 + +
Brucella abortus 86/8/59 Weybridge, biotype 2 2 + +
Brucella abortus NCTC 10093, biotype 1 2 + +
Brucella abortus NCTC 10501, biotype 2 2 + +
Brucella abortus NCTC 10502, biotype 3 2 + +
Brucella abortus NCTC 10503, biotype 4 2 + +
Brucella abortus NCTC 10504, biotype 5 2 + +
Brucella abortus NCTC 10505, biotype 6 2 + +
Brucella abortus NCTC 10506, biotype 7 2 + +
Brucella abortus NCTC 10507, biotype 9 2 + +
Brucella melitensis 1, biotype 2 2 + +
Brucella melitensis 11, biotype 1 2 + +
Brucella melitensis 72, biotype 3 2 + +
Brucella melitensis 16M_NCTC_10094, biotype 1 2 + +
Brucella melitensis NCTC 10508, biotype 2 2 + +
Brucella melitensis NCTC 10509, biotype 3 2 + +
Brucella suis 9, biotype 2 2 + +
Brucella suis 9/2002, biotype 1 2 + +
Brucella suis NCTC 10510, biotype 2 2 + +
Brucella suis NCTC 10511, biotype 3 2 + +
Brucella canis 125, biotype 1 2 + +
Brucella canis RM_6/66_ATCC_23365, biotype 1 2 + +
Brucella neotomae NCTC 10084 SK33 2 + +
Brucella maris 2410 2 + +
Brucella maris 2411 2 + +
Brucella maris NCTC 12890 2 + +
Brucella maris NCTC 12891 2 + +
Burkholderia pseudomallei HAMBI 33 1 ) )
Francisella tularensis LVS (ATCC 29684) 5 ) )
Mesorhizobium huakuii HAMBI 2035 T 1 ) )
Mesorhizobium loti HAMBI 1129 T 1 ) )
Ochrobactrum anthropi HAMBI 2402 1 ) )
Rhizobium calligum HAMBI 2326 T 1 ) )
Rhizobium galegae HAMBI 540 T 1 ) )
Rhizobium leguminosarum HAMBI 14 T 1 ) )
Sinorhizobium meliloti HAMBI 2148 T 1 ) )
Yersinia pestis EV76-c 6 ) )
Y. pestis KIM D1 6 ) )
aThe sources are as follows: 1, Department of Applied Chemistry and Microbiology, Faculty of Agriculture and For-
estry, University of Helsinki, Finland; 2, Institute of Microbiology, German Armed Forces, Munich, Germany; 3, Turku
University Central Hospital and Helsinki District Central Hospital Laboratory Diagnostics HUSLAB; 4, Laboratory
Strain Collection, Finnish Food Safety Authority Evira; 5, Laboratory Strain Collection, FOI, Umea˚, Sweden; 6, Labora-
tory Strain Collection, Department of Bacteriology and Immunology, University of Helsinki; 7, Puriﬁed from a com-
mercial insecticide.
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kurstaki sequence was not found in other microorganism
sequences available in the GenBank database, except in
B. thuringiensis when analysed by the BLAST algorithm.
PCR and sequencing equipment and procedures
Optimal primer concentrations for the Brucella spp. and
B. thuringiensis assays, as well as for all RAZOR platform
assays, were determined graphically from plotted reaction
curves, using both the lowest crossing threshold (Ct) and the
highest ﬂuorescence signal as the criteria in a matrix-type
evaluation. On the basis of re-evaluation of the primer and
probe concentrations in the assays targeting the B. anthracis
cap and pag, F. tularensis 23 kDa and Y. pestis pla genes on
the ABI platform, no changes were made to those reported
earlier [6].
All PCR assays on the ABI 7300 (software version 1.2.3)
or ABI 7500 (software version 1.3.1) instruments were run
in a ﬁnal volume of 25 lL, consisting of 12.5 lL of 2 · mas-
ter mix (ABI), 2.5 lL of puriﬁed DNA template, 2.5 lL of
internal positive control (IPC) master mix and 0.5 lL of IPC
TABLE 3. Speciﬁcity panel for and
results of the assay for Bacillus
thuringiensis
Species Strain Sourcea
Agent (target gene)
B. thuringiensis (cry)b
ABI 7300/7500 RAZOR
Bacillus anthracis ATCC 4229 (pXO1)/pXO2+) 3 ) )
B. anthracis Sterne 7702 (pXO1+/pXO2)) 3 ) )
Bacillus cereus ELMI 21 3 ) )
Bacillus circulans HAMBI 474 1 ) )
Bacillus coagulans HAMBI 385 1 ) )
Bacillus licheniformis ELMI 325 3 ) )
Bacillus mycoides ELMI 44 3 ) )
Bacillus subtilis HAMBI 251 1 ) )
B. thuringiensis ELMI 123 3 + +
B. thuringiensis ssp. kurstaki-aizaway 6 + +
Brucella melitensis 72, biotype 3 2 ) )
Francisella tularensis LVS (ATCC 29684) 4 ) )
Yersinia pestis EV76-c 5 ) )
Y. pestis KIM D1 5 ) )
aThe sources are as follows: 1, Department of Applied Chemistry and Microbiology, Faculty of Agriculture and For-
estry, University of Helsinki, Finland; 2, Institute of Microbiology, German Armed Forces, Munich, Germany; 3, Labo-
ratory Strain Collection, Finnish Food Safety Authority Evira; 4, Laboratory Strain Collection, FOI, Umea˚, Sweden; 5,
Laboratory Strain Collection, Department of Bacteriology and Immunology, University of Helsinki; 6, Puriﬁed from a
commercial insecticide.
bThe results were identical with both variants of the B. thuringiensis assay: the ﬁeld test and the optimized test with
higher sensitivity.
TABLE 4. Primers and probes for the developed real-time PCR assays for the ABI and RAZOR platforms
Target organism
Target
gene Primer and probe sequences
Final concentration (nM) Amplicon
length (bp) ReferenceABI 7300/7500 RAZOR
Brucella spp. IS711 Forward 5¢-GGC CTA CCG CTG CGA AT-3¢ 300 300 54 This study
Reverse 5¢-TTG CGG ACA GTC ACC ATA ATG-3¢ 900 300
Probe 5¢-FAM-AAG CCA ACA CCC GGC-MGBNFQ-3¢ 250 250
Bacillus thuringiensis crya Forward 5¢-GCT TCT CCT GTC GGT TTT TCG-3¢ 900 900 66 This study
Reverse 5¢-TGC ATT TCC CAT GGT TCC A-3¢ 900 900
Probe 5¢-FAM-CCA GAA TTC ACG TTT CC-MGBNFQ-3¢ 250 250
cryTb Forward 5¢-ATG GCT TCT CCT GTA GGG TTT TC-3¢ 300 300 71 This study
Reverse 5¢-GCT GCA TTT CCC ATA GTT CCA-3¢ 900 900
Probe 5¢-FAM-CCA GAA TTC ACT TTT CCG CT-MGBNFQ-3¢ 250 250
Bacillus anthracis cap Forward 5¢-TTG GGA ACG TGT GGA TGA TTT-3¢ 300 300 69 [6]
Reverse 5¢-TCA GGG CGG CAA TTC ATA AT-3¢ 900 900
Probe 5¢-FAM-TAG TAA TCT AGC TCC AAT TGT-MGBNFQ-3¢ 250 250
pag Forward 5¢-CGG ATA GCG GCG GTT AAT C-3¢ 300 300 85 [6]
Reverse 5¢-CAA ATG CTA TTT TAA GGG CTT CTT TT-3¢ 900 900
Probe 5¢-FAM-TAG AAA CGA CTA AAC CGG ATA T-MGBNFQ-3¢ 250 250
Francisella tularensis 23 kDa Forward 5¢-TGA GAT GAT AAC AAG ACA ACA GGT AAC A-3¢ 300 900 84 [6]
Reverse 5¢-GGA TGA GAT CCT ATA CAT GCA GTA GGA -3¢ 900 900
Probe 5¢-FAM-CCA TTC ATG TGA GAA CTG-MGBNFQ-3¢ 250 250
Yersinia pestis pla Forward 5¢-GAA AGG AGT GCG GGT AAT AGG TT-3¢ 50 300 63 [6]
Reverse 5¢-CCT GCA AGT CCA ATA TAT GGC ATA-3¢ 300 900
Probe 5¢-FAM-TAA CCA GCG CTT TTC-MGBNFQ-3¢ 250 250
aField test; based on NBCI databank accession number U87397.
bOptimized assay based on the partially sequenced cry of the TUREX insecticide powder.
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synthetic DNA, and appropriate volumes of primer and
probe solutions to obtain the ﬁnal concentrations presented
in Table 4. After an initial 50C incubation for 2 min for
activation of UNG enzyme, and 95C for 10 min for dena-
turation of template and activation of the polymerase
enzyme, all assays on the ABI platforms were performed by
repeating the following procedure 40 times: 95C for 15 s,
and 60C for 1 min. With these thermocycling parameters,
the PCR took approximately 100 min.
The RAZOR instrument (software version 1, beta 1; Idaho
Technology) allows the use of only three different tempera-
tures with three steps and a maximum of 4 min per step for
thermocycling. The initial 10-min heating step used with the
ABI platform was therefore not applicable. Two types of
pouch were used with the RAZOR instrument: one type has
four inlet ports for four samples, which are each drawn to
three wells (4 · 3 pouches). The other type contains six
inlet ports for six samples, and each sample is run in dupli-
cate (6 · 2 pouches). The volume of the PCR reaction mix-
ture for one syringe used for infusion of the 4 · 3 pouch
was 500 lL, consisting of 250 lL of the master mix (Takara
Premix Ex Taq; Takara, Shiga, Japan), 50 lL of template, and
appropriate volumes of primer and probe solutions and
DNase/RNase-free water to obtain the ﬁnal concentrations
presented in Table 4. For the 6 · 2 pouch, the syringe vol-
ume of the reaction mixture was 333 lL. Finally, however,
the ﬁnal reaction volume was 100 lL per well with both
types of pouch.
The default thermocycling programme of the RAZOR
instrument consisted of an initial denaturation step at 94C
for 2 min, followed by 55 cycles at 94C for 10 s and 60C
for 30 s. The use of the Takara Premix Ex Taq polymerase
allowed shortening of the initial denaturing phase to 10 s and
the cycle denaturing phase at 94C to 5 s. With these ther-
mocycling parameters, the reaction took approximately
40 min to run, after which the results could be viewed on
the screen of an attached computer.
The sensitivities (limits of detection) of the assays were
estimated with either of the technically similar ABI (7300 or
7500) and the RAZOR system, using ten-fold serial dilutions
of corresponding DNA as template.
To determine the partial DNA target sequence of the
commercial B. thuringiensis ssp. kurstaki-aizaway preparation
for further optimization of the used primer pair, cloned
(TOPO TA cloning kit; Invitrogen Corporation, Carlsbad,
CA, USA) PCR products obtained with newly designed
outer PCR primers (data not shown) were analysed with
an automated ABI 3130XL DNA sequencer (ABI), using Big
Dye chemistry (ABI) and previously published procedures
[15].
Trial with the B. thuringiensis training assay in the mobile
ﬁeld laboratory
The mobile ﬁeld laboratory met BSL-3 safety level standards,
and had been designed for the Finnish Defence Forces. It
was equipped with a line of steel cabinets consisting of: a
sample hatch, into which a sample can be safely transported
from the outside; a class III microbial safety cabinet (MSC); a
class II MSC; and an autoclave for safe disposal of wastes.
The real-time PCR instrument was placed inside the ﬁeld lab-
oratory outside of the cabinets.
In order to estimate the number of viable B. thuringiensis
spores to be used in the following trial, serial dilutions in
phosphate-buffered saline (PBS) of a TUREX insecticide sam-
ple were cultivated in Tryptone Soy Agar medium. The total
number of spores in the preparation was estimated in a
microscopy counting chamber (Bu¨rker-Tu¨rk, Marienfeld,
Germany). Field-training sample material was prepared by
mixing the TUREX powder thoroughly with rye ﬂour of sim-
ilar granularity and colour. The samples consisted of 0.5-g
aliquots of the rye ﬂour containing 10% or 1% TUREX in 50-
mL sample tubes. Unspiked rye ﬂour was used as negative
control. Three coded training samples containing predeter-
mined amounts of TUREX powder and rye ﬂour were trans-
ported to a mobile ﬁeld laboratory, where the sample
processing and real-time PCR analyses with the training assay
using the cry primers and probe took place. One negative
sample containing PBS only was included in the sample pro-
cessing to detect any carryover contaminants.
To obtain the template for PCR analysis during the trial,
samples of the powder substance were suspended in PBS.
After thorough mixing, 1 mL of the suspension was ﬁltered
through a 1.2-lm ﬁlter (Whatman GmbH, Dassel, Germany),
and this was followed by a second ﬁltration through a
0.2-lm ﬁlter (Whatman GmbH). The sample ﬁltration was
performed inside a class III MSC, and this was followed by
pipetting of all PCR reagents and the templates into the
reaction pouches inside a class II MSC before analysis with
the RAZOR instrument.
Results
The analytical speciﬁcity results obtained with the assays for
the agents of anthrax, tularemia and plague, as well as with
the developed Brucella assay, are displayed in Tables 1 and 2.
No unspeciﬁc cross-reactivity of the assays with other bacte-
ria was observed in these experiments.
The sensitivities of the comparative PCR assays ranged
from 10 to 100 fg of speciﬁc chromosomal target DNA
per reaction, using either the ABI 7300/7500 platform
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(0.4–4 ng/mL) or the RAZOR ﬁeld instrument (0.1–1 ng/mL)
(Table 5). However, no difference in performance between
the two technology platforms (ABI and RAZOR) was
observed when optimally puriﬁed target DNA was used as
template in the assays for anthrax, brucellosis, tularemia and
plague.
The analytical speciﬁcity results obtained with the use of
closely related bacteria as template in the developed ﬁeld-
training assay for B. thuringiensis are shown in Table 3. No
cross-reactivity with other Bacillus species was detected. The
detection ranges of the ﬁeld assay with puriﬁed TUREX
insecticide as template were 250–25 ng of powder per reac-
tion with the ABI instrument, and 50 lg to 1 ng per reaction
with the RAZOR instrument. No ampliﬁcation occurred at
concentrations outside these ranges. To determine the cause
of this notable difference in the detection range between the
two platforms, we sequenced the partial cry target of the
commercial product, and, indeed, the TUREX B. thuringiensis
ssp. kurstaki-aizaway target sequence revealed minor mis-
matches in the targeted primer and probe sequence areas
(two mismatches were found in the forward primer and one
mismatch both in the reverse primer and in the probe) as
compared with the original B. thuringiensis ssp. kurstaki-
aizaway sequence used as the basis for primer and probe
selection (GenBank accession number U87397).
After modiﬁcation of the oligonucleotide sequences to
make them identical to the corresponding sequence in TU-
REX powder, the sensitivity of the assays with this prepara-
tion as template increased considerably, and only a slight
difference between the assay platforms continued to be
observed, the detection ranges being 250 ng to 25 pg of
powder per 25-lL reaction (10 lg/mL to 1 ng/mL) with the
ABI system, and 50 lg to 100 pg per 100-lL reaction
(500 lg/mL to 1 ng/mL) with the RAZOR instrument. This
consistency in the wider range of analytical sensitivity
suggests greater chemical robustness in the PCR process
within the RAZOR platform. As with the originally designed
assay, no cross-reactivity with other Bacillus strains was seen
with the modiﬁed assay (Table 3; Fig. 1). When puriﬁed
cloned target DNA from the TUREX preparation was used
as template in the modiﬁed assay, no signiﬁcant difference in
assay sensitivity (100 ag per reaction) between the two plat-
forms was detected (Table 5). With chromosomal DNA
puriﬁed from bacterial isolates grown from the TUREX pow-
der, the sensitivities of the assays were 1 ng per reaction
and 100 fg per reaction on the ABI 7300/7500 platforms, and
100 fg per reaction and 100 fg per reaction with the RAZOR
system, with cry (originally designed) and cryT (modiﬁed)
assays, respectively, suggesting greater analytical ﬂexibility of
the RAZOR detection system with primers and a probe that
contained mismatches (Table 5).
In a blindly performed ﬁeld test with the RAZOR instru-
ment in a mobile laboratory, analytical tests with two B. thur-
ingiensis-spiked rye ﬂour samples as well as a negative
control sample containing only rye ﬂour were determined
correctly as positives and negative, respectively (Fig. 2).
Discussion
Sensitive and rapid real-time PCR detection methods have,
especially in the aftermath of the anthrax letters of 2001,
been developed and reﬁned for the CDC list A agents,
including the causative agents of anthrax [16,17], tularemia
[18,19] and plague [20,21]. Diagnostics for the CDC list B
agents, such as Brucella spp., the cause of brucellosis, have
also been updated and further developed [11,22]. All of
these reports focus on the identiﬁcation of single or closely
related pathogens, and mainly describe methodologies that
are conﬁned to stationary clinical diagnostic laboratories.
However, there is a deﬁnite need for a broader range of
applications for detection and identiﬁcation of a panel of
selected agents under ﬁeld conditions, to be used, for exam-
ple, by the veterinary public health service. All four agents
singled out above are zoonotic, and the ﬁrst indication of
their intentional release might well arise as an animal disease
outbreak. There are only a few earlier reports describing
features of commercial hand-held or portable instruments
for rapid diagnosis of bioterrorism agents [23–26], but there
seem to be no previous scientiﬁc reports on actual ﬁeld test-
ing of such devices.
Notable differences in analytical sensitivity or speciﬁcity
performance between the ABI and RAZOR platforms were
not observed in our study when optimally puriﬁed template
DNA and target-speciﬁc oligonucleotides were used. Similar
TABLE 5. The sensitivities of the developed real-time PCR
assays on the two different platforms
Target organism
Target
gene
Sensitivity (limit of detection)a
ABI 7300/7500
instruments
RAZOR ﬁeld
instrument
Brucella spp. IS711 10 fg 10 fg
Bacillus anthracis cap 100 fg 100 fg
pag 10 fg 10 fg
Francisella tularensis 23 kDa 10 fg 10 fg
Yersinia pestis pla 10 fg 10 fg
Bacillus thuringiensis cryTb 100 fg 100 fg
B. thuringiensis cryTc 100 agc 100 agc
aAmount of genomic DNA as template.
bOptimized assay with modiﬁed oligonucleotides based on the partially
sequenced cry of TUREX insecticide powder.
cAmount of cloned plasmid DNA as template.
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ﬁndings have been recently reported by Christensen et al.
[27]. They compared assay performance in detecting biologi-
cal threat agents with the RAPID, LightCycler and the Smart
Cycler platforms under optimal laboratory conditions. The
analytical limits of detection in that report varied between
50 and 100 fg for most assays [27], which is in concordance
with our results. However, implementation of these method-
ologies in ﬁeld conditions was not performed as in our
study. We have successfully utilized the ABI 7300 instrument
in a mobile laboratory setting [26], and in this current article
we describe the development of a ﬁeld-training assay for
Bacillus spore detection that was evaluated under ﬁeld condi-
tions with the RAZOR instrument. During the development
of this ﬁeld assay, we observed a slight increase in assay
robustness with the RAZOR instrument when using oligo-
nucleotides that contained mismatches with the target
sequence, as well as when suboptimally prepared template
was analysed. The demonstrated difference in the detection
range of the instrument platforms may be partially explained
by the larger reaction volume (100 lL) in the RAZOR
instrument than in the ABI instrument (25 lL). This
larger reaction volume may contribute to resistance against
inhibitors of the PCR. On the other hand, we did not
observe any cross-reactivity deriving from unspeciﬁc oli-
gonuclotide hybridization with either of the platforms.
The ABI 7300 instrument is heavy (29 kg) and requires
more space (width · depth · height = 34 · 45 · 49 cm), but
it is versatile, and the tungsten–halogen lamp technology has,
in our hands, proven to be robust enough for mobile labora-
tory conditions [26]. Conversely, the RAZOR instrument was
originally designed for ﬁeld use, and because it is smaller and
lighter (width · depth · height = 17 · 11 · 23 cm, weight =
4.1 kg), it can be easily transferred by carrying. However, both
the ABI thermocycler and the RAZOR instrument are cur-
rently dependent on a ﬁeld laboratory or similar setting for
sample processing and DNA puriﬁcation. Furthermore, there
are signiﬁcant differences in the time needed for thermocycling
between the two platforms, i.e. 40 min and 100 min for the
RAZOR and the ABI platform, respectively.
The development of the assays that were used for com-
parison of these two assay platforms for the agents of
anthrax, tularemia and plague has been published previously
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FIG. 1. A representative Bacillus thuringiensis real-time PCR ampliﬁcation plot obtained with the RAZOR instrument to test the speciﬁcity of the
optimized primers (target gene cryT). Four different Bacillus strains (ELMI 21, ELMI 44, ELMI 123 and ELMI 325) were analysed. As the positive
control, 400 pg of chromosomal DNA from the TUREX insecticide powder was used per reaction. No template controls (NTCs) were included
as negative controls. All assays were performed in duplicate, using the 6 · 2 pouches. Both the positive control (ampliﬁcation curves 1 and 2)
and the B. thuringiensis strain (ELMI 123; ampliﬁcation curves 3 and 4) showed ampliﬁcation, the average Ct values being 17.1 and 21.6, respec-
tively. The other Bacillus strains tested (ELMI 21, ELMI 44 and ELMI 325), as well as the NTCs, were negative.
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[6]. The gene target for the newly developed Brucella spp.
assay was selected on the basis of the ﬁndings of Redkar
et al. [10] regarding their development of the Brucella spe-
cies-speciﬁc assays. However, recently, Al Dahouk et al. [28]
evaluated Brucella spp. genus-speciﬁc and species-speciﬁc
real-time PCR assays, and found that not all strains of Bru-
cella abortus or Brucella suis were detected by the assay
developed by Redkar et al. [10]. Therefore, for our study,
primers and probes targeting IS711 were newly designed to
detect all species of the genus Brucella for rapid broad-range
detection preceding conﬁrmatory species-speciﬁc detection
and identiﬁcation in a stationary laboratory. In fact, recently,
an assay for Brucella spp. using similar oligonucleotide targets
on IS711 as well as multiple assays speciﬁc for different Bru-
cella species have been developed [29].
The sensitivity of our Brucella spp. assay proved to be
slightly greater (10 fg per reaction) than that reported by Al
Dahouk et al. in 2007 for their bcsp31 assay (16–18 fg per
reaction). Furthermore, in a recently published comparative
study by Bounaadja et al. on the target genes for Brucella spp.
identiﬁcation, the authors concluded that IS711 was a more
sensitive target than bcsp31 and per. However, in their study,
the sensitivity varied between different Brucella species,
owing to different copy numbers of the IS711 sequence in
each species [30].
The plasmid-encoded cry genes constitute a speciﬁc
feature of the different B. thuringiensis species [14] in the
otherwise genetically quite homologous B. cereus group, and
are therefore useful in speciﬁc assays for the differentiation
of B. thuringiensis from other Bacillus species. The simpliﬁed
sample preparation procedure described in this article for
the surrogate B. anthracis TUREX powder bypasses the need
for sensitive biochemical materials or equipment, such as
speciﬁc enzymes or centrifuges, before PCR ampliﬁcation of
the analyte. Of note is that, the pretreatment procedure
applies, as such, only to the concentrated insecticide spore
preparation (TUREX) used in this study. Both the spore
plate count and the direct estimation of the number of
spores with the counting chamber indicated a level of
approximately 2 · 1010 spores/g of TUREX powder. In our
hands, the described ﬁeld-training assay, starting with the
devised simpliﬁed preparation of the sample and using the
RAZOR instrument, is straightforward and safe. Therefore, it
is adequate for ﬁeld-training purposes, e.g. for analyses of
powder letters presumably containing anthrax spores.
These assays provide rapid tools for the speciﬁc detection
of four biological threat agents. Although no notable differ-
ences between the ABI 7300/7500 and RAZOR instruments
were observed in analytical sensitivity or speciﬁcity under
optimal conditions, the duration of thermocycling with the
RAZOR instrument was signiﬁcantly shorter (40 min vs.
100 min with ABI 7300/7500). Furthermore, the physical
robustness and smaller size of the RAZOR apparatus adds
to its usefulness under ﬁeld conditions. Moreover, our
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FIG. 2. Analytical test results from the
ﬁeld trial with the RAZOR instrument.
Positive controls (ampliﬁcation curves 1
and 2) and Bacillus thuringiesis-positive
samples (ampliﬁcation curves 3 and 4,
containing 0.05 g of TUREX insecticide
combined with 0.5 g of rye ﬂour, and
ampliﬁcation curves 5 and 6, containing
0.005 g of TUREX insecticide combined
with 0.5 g of rye ﬂour) showed the
expected positive ﬂuorescence signals.
Neither the negative samples nor the
non-template control showed any PCR
reactivity.
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results suggest that the RAZOR chemistry may be more
resistant to suboptimal PCR conditions. However, integrated
or simpliﬁed sample preparation procedures, as described
here for Bacillus spore detection, should be further devel-
oped.
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